- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/295 - Polyvalent viral antigensMixtures of viral and bacterial antigens
Patent holdings for IPC class A61K 39/295
Total number of patents in this class: 772
10-year publication summary
|
28
|
42
|
53
|
42
|
53
|
54
|
41
|
66
|
29
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet International B.V. | 1342 |
28 |
| Zoetis Services LLC | 1534 |
27 |
| Intervet Inc. | 918 |
23 |
| Boehringer Ingelheim Animal Health USA Inc. | 419 |
17 |
| Glaxosmithkline Biologicals S.A. | 1595 |
16 |
| Takeda Vaccines, Inc. | 207 |
12 |
| Novartis AG | 10338 |
11 |
| Sanofi Pasteur | 378 |
11 |
| Pfizer Inc. | 3375 |
10 |
| The Trustees of the University of Pennsylvania | 4403 |
9 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
9 |
| Institut Pasteur | 787 |
8 |
| Modernatx, Inc. | 1282 |
8 |
| Variation Biotechnologies, Inc. | 59 |
8 |
| The Regents of the University of California | 20590 |
7 |
| Boehringer Ingelheim Vetmedica, Inc. | 104 |
7 |
| The Council of the Queensland Institute of Medical Research | 165 |
7 |
| Institute of Microbiology, Chinese Academy of Sciences | 129 |
7 |
| The Governors of the University of Alberta | 873 |
6 |
| University of Massachusetts | 2300 |
6 |
| Other owners | 535 |